FLU INFLUENZA (Abbott) at Dr. Essa Lab

FLU INFLUENZA (Abbott) at Dr. Essa Lab

The FLU INFLUENZA (Abbott) test at Dr. Essa Lab is a state-of-the-art diagnostic assay designed to rapidly and accurately detect the presence of Influenza A and Influenza B viruses in respiratory specimens. Influenza, commonly known as the flu, is a highly contagious viral infection that affects the respiratory system, including the nose, throat, and lungs. Because the symptoms of influenza closely mimic those of other respiratory pathogens, such as the common cold, respiratory syncytial virus (RSV), and COVID-19, precise laboratory differentiation is critical for effective clinical management. Utilizing Abbott’s advanced diagnostic technology, this test provides healthcare providers with reliable, actionable results within a minimal timeframe, enabling timely intervention and treatment. Dr. Essa Laboratory and Diagnostic Centre, a trusted name in pathology services across Karachi and Pakistan since 1987, offers this specialized testing to ensure patients receive the highest standard of care.

How the examination works relies on the detection of specific viral components. Depending on the specific Abbott platform utilized—ranging from rapid molecular isothermal nucleic acid amplification to high-throughput immunoassay systems—the test identifies either the genetic material (RNA) or specific viral antigens of Influenza A and Influenza B. The primary anatomical structures evaluated during this procedure are the mucosal linings of the nasopharynx and the nasal cavity, where the influenza virus actively replicates. By obtaining a sample from these areas, the test captures a high concentration of viral particles, maximizing diagnostic sensitivity. The clinical importance of the FLU INFLUENZA (Abbott) test cannot be overstated; it allows clinicians to distinguish influenza from other febrile illnesses, prevents the inappropriate use of antibiotics, guides the prescription of specific antiviral medications like oseltamivir, and aids in public health surveillance and outbreak control within communities.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the FLU INFLUENZA (Abbott) test at Dr. Essa Lab is straightforward, as it is a non-invasive respiratory swab test. To ensure the most accurate results, patients should follow these guidelines:

• No fasting is required; you may eat and drink normally before the test.
• Avoid using nasal sprays, drops, or rinses for at least four to six hours prior to sample collection, as these substances can dilute the viral load or interfere with the assay chemistry.
• Inform the healthcare professional or phlebotomist if you have recently had a nosebleed, nasal surgery, or if you have a deviated septum, as this helps them choose the optimal nostril for swab insertion.
• If you are currently taking antiviral medications, inform the laboratory staff, as this can affect viral replication and test sensitivity.
• Wear a mask to the diagnostic center to prevent the potential spread of respiratory droplets to other patients and staff members.

During the Procedure

The collection of the respiratory specimen for the FLU INFLUENZA (Abbott) test is performed by a trained laboratory technician or nurse at Dr. Essa Lab, ensuring both safety and comfort. The patient is typically seated in a comfortable upright position with their head tilted slightly backward to facilitate access to the nasal passages. The technician uses a sterile, specialized dacron or polyester swab with a flexible plastic shaft. The swab is gently inserted through the nostril and guided parallel to the palate until it reaches the posterior nasopharynx, which is the upper part of the throat behind the nose. Once in place, the swab is gently rotated several times to collect epithelial cells and secretions containing the viral particles, and then slowly withdrawn. The entire collection process takes less than thirty seconds. While the procedure is not painful, it may cause a brief, self-limiting tickling sensation, mild discomfort, or trigger a cough or watery eyes. The collected swab is immediately placed into a viral transport medium or directly into the Abbott test cartridge to maintain sample integrity. Safety protocols, including the use of personal protective equipment (PPE) by the staff, are strictly maintained throughout the process to prevent cross-contamination.

When is a FLU INFLUENZA (Abbott) Performed?

Suspected Seasonal Influenza Infection

Physicians frequently request the FLU INFLUENZA (Abbott) test during periods of increased influenza activity, typically during the winter months and monsoon transitions in Pakistan. Patients presenting with sudden-onset high fever, severe chills, generalized body aches, headache, and profound fatigue are prime candidates for this test. Because seasonal influenza can spread rapidly through households, workplaces, and schools, establishing an early and accurate diagnosis helps in initiating prompt isolation measures and targeted antiviral therapy, which is most effective when started within forty-eight hours of symptom onset.

High-Risk Patients with Respiratory Symptoms

For individuals at high risk of developing severe influenza-related complications, timely diagnosis is critical. This high-risk category includes elderly individuals, young children, pregnant women, and patients with chronic medical conditions such as asthma, chronic obstructive pulmonary disease (COPD), cardiovascular disease, diabetes, or immunosuppression. When these patients present with respiratory symptoms, the FLU INFLUENZA (Abbott) test is performed immediately to determine if influenza is the underlying cause, allowing clinicians to monitor them closely and initiate aggressive management to prevent complications like pneumonia, bronchitis, or acute respiratory distress syndrome (ARDS).

Differential Diagnosis of Respiratory Illnesses

Many respiratory pathogens present with overlapping clinical signs, making clinical diagnosis challenging. Symptoms such as cough, sore throat, rhinorrhea, and fever can be caused by influenza, SARS-CoV-2, RSV, adenovirus, or bacterial infections. The FLU INFLUENZA (Abbott) test assists physicians in differential diagnosis by confirming or ruling out influenza. This prevents diagnostic ambiguity, reduces patient anxiety, and ensures that the patient is placed on the correct therapeutic pathway rather than receiving empirical treatments that may not target the actual cause of their illness.

Outbreak Management and Surveillance

In institutional settings such as hospitals, nursing homes, schools, and daycares, a single case of influenza can quickly escalate into a major outbreak. The FLU INFLUENZA (Abbott) test is performed to rapidly identify index cases, enabling infection control teams to implement cohorting, quarantine, and prophylactic antiviral strategies. Additionally, Dr. Essa Lab contributes to regional public health surveillance by reporting positive influenza cases, helping health authorities track viral circulation patterns, detect emerging strains, and assess the efficacy of seasonal influenza vaccines.

Pre-admission Screening in Healthcare Settings

Prior to admitting patients with respiratory symptoms to communal wards or specialized units, hospitals often require rapid screening for highly contagious pathogens. The FLU INFLUENZA (Abbott) test serves as an essential pre-admission screening tool. By rapidly identifying influenza-positive patients, healthcare facilities can allocate appropriate isolation rooms, protect vulnerable hospitalized populations from nosocomial transmission, and maintain a safe environment for both patients and healthcare workers.

What Does a FLU INFLUENZA (Abbott) Detect?

The FLU INFLUENZA (Abbott) test is highly specific and designed to detect several critical clinical parameters and viral markers. Specifically, the test detects:

• The presence of Influenza A viral antigens or nucleic acids, which represent the most common cause of severe influenza epidemics.
• The presence of Influenza B viral antigens or nucleic acids, which often circulate alongside Influenza A and can cause severe disease, particularly in children.
• Active viral replication within the upper respiratory tract, indicating an ongoing infection.
• Specific viral proteins, such as nucleoproteins, that are unique to the influenza virus family.
• The differentiation between Influenza A and Influenza B infections, which is vital for epidemiological tracking.
• The presence of viral RNA sequences highly conserved across various influenza strains.
• The adequacy of the respiratory specimen, verified through internal control markers built into the Abbott assay.
• Potential co-infections when interpreted alongside other respiratory panels.
• Early-stage infections where viral shedding is high.
• Late-stage infections where viral shedding may be declining but still detectable.
• The presence of seasonal flu strains including H1N1 and H3N2 subtypes under the Influenza A umbrella.
• Influenza B lineages, including Victoria and Yamagata lineages.
• Viral clearance in patients undergoing post-treatment evaluation.
• The etiology of acute respiratory distress syndrome in severe cases.
• The underlying cause of secondary bacterial pneumonia complications.
• The source of febrile seizures in pediatric patients presenting with high fever.
• The cause of exacerbations in patients with pre-existing asthma or COPD.
• The viral origin of croup or bronchiolitis in young children.
• The presence of viral particles in asymptomatic carriers during close-contact screening.
• The success of infection control measures in institutional outbreaks.
• The specific pathogen responsible for nosocomial respiratory infections.
• The necessity for targeted antiviral therapy rather than broad-spectrum antibiotics.
• The viral load level qualitatively, helping to assess infectivity.
• The presence of intact viral structures or genetic fragments in the nasopharyngeal mucosa.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Laboratory and Diagnostic Centre, we understand that timely results are crucial for managing acute viral infections like influenza. The FLU INFLUENZA (Abbott) test is processed with high priority due to its clinical urgency. Typically, results are available within a few hours of sample collection, depending on the specific branch and workload. Dr. Essa Lab offers multiple convenient ways for patients to access their diagnostic reports. Patients can receive real-time updates via SMS and download their verified PDF reports directly from the official Dr. Essa Lab online portal. Additionally, reports can be delivered via WhatsApp or collected physically from any of our numerous diagnostic centers across Karachi and other cities. This seamless digital reporting system ensures that patients and their attending physicians can access critical diagnostic data without delay, facilitating immediate clinical decisions and treatment initiation.

FLU INFLUENZA (Abbott) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Influenza A RNA / Antigen	Not Detected (Negative)	Detected (Positive) – Indicates active Influenza A infection
Influenza B RNA / Antigen	Not Detected (Negative)	Detected (Positive) – Indicates active Influenza B infection
Internal Quality Control	Valid / Passed	Invalid – Suggests insufficient sample or technical error
Specimen Adequacy	Satisfactory cellular content	Unsatisfactory – Requires resampling due to poor collection
Co-infection Status	Single pathogen or negative	Multiple pathogens detected (e.g., Flu and COVID-19 co-infection)
Clinical Correlation	No active influenza infection	Active viral replication matching clinical symptoms
Antiviral Susceptibility Indicator	Not applicable (Standard strain)	Atypical clinical response suggesting potential resistance

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for FLU INFLUENZA (Abbott)?

• Experienced healthcare professionals and pathologists dedicated to accurate diagnostic reporting.
• Patient-focused care designed to make the testing process comfortable and stress-free.
• Quality diagnostic services utilizing advanced Abbott testing platforms and reagents.
• Professional reporting with strict quality control measures to eliminate false results.
• Modern diagnostic approach integrating digital technology for seamless patient experiences.
• Comfortable environment across all diagnostic centers, prioritizing patient safety and hygiene.
• Convenient locations throughout Karachi and other regions, making services highly accessible.
• Commitment to accurate diagnosis, backed by a legacy of trust in pathology since 1987.